Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

This is the first prospective study of deferasirox in adult allogeneic hematopoietic stem cell transplant recipients with transfusional iron overload in hematologic malignancies. Patients at least six months post transplant were treated with deferasirox at a starting dose of 10 mg/kg/day for 52 week...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vallejo, Carlos, Batlle, Montserrat, Vázquez, Lourdes, Solano, Carlos, Sampol, Antonia, Duarte, Rafael, Hernández, Dolores, López, Javier, Rovira, Montserrat, Jiménez, Santiago, Valcárcel, David, Belloch, Vicente, Jiménez, Mónica, Jarque, Isidro
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2014
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181261/
https://ncbi.nlm.nih.gov/pubmed/24997153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.105908
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados